Hide

FocusBar

Subscribe to Premium Member
Switch to:
Insider Position Date Buy/Sell Shares Shares Owned Following This Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Baker Thomas EDirector2013-04-04Buy2,46377,779$8.8421.813.01Link
JEREMIAH BARABARA SDirector2013-04-04Buy2,89853,802$8.8425.613.01Link
Philip George MDirector2013-04-04Buy53352,862$8.844.713.01Link
JEREMIAH BARABARA SDirector2012-12-21Buy2,45142,759$7.8919.326.62Link
Philip George MDirector2012-12-21Buy58844,184$7.894.626.62Link
Baker Thomas EDirector2012-12-21Buy2,71867,171$7.8921.426.62Link
JEREMIAH BARABARA SDirector2012-09-28Buy2,35040,308$8.1119.123.18Link
Baker Thomas EDirector2012-09-28Buy2,59764,453$8.1121.123.18Link
Philip George MDirector2012-09-28Buy56143,596$8.114.523.18Link
Rendulic Mark REVP, Retail Banking2012-08-13Buy7,50051,075$8.0960.723.49Link
BARRY RICHARD MChief Credit Officer2012-08-06Buy5,00055,079$7.8639.327.1Link
Crosby Gary MCOO2012-08-06Buy7,50095,451$7.9459.625.82Link
CANTARA DANIEL EEVP Commercial Business Svcs2012-08-03Buy15,000159,118$7.88118.226.78Link
KOELMEL JOHN RPresident & CEO
(Click for the stocks that their CEOs have bought)
2012-08-01Buy25,000444,693$7.53188.332.67Link
Philip George MDirector2012-07-31Buy5,00043,035$7.5737.931.97Link
FLORIO CARL ADirector2012-07-31Buy5,000728,643$7.5537.832.32Link
Robinson Peter B.Director2012-07-31Buy13,00023,460$7.6299.131.1Link
Sommer OliverEVP, Corporate Development2012-08-02Buy5,00069,224$7.4237.134.64Link
Highsmith Carlton LDirector2012-07-31Buy15,00037,303$7.62114.331.1Link
Norwood Gregory WCFO2012-08-02Buy10,00093,523$7.4774.733.73Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.


GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK